Literature DB >> 31893407

Fatal Alliance of Hypoxia-/HIF-1α-Driven Microenvironmental Traits Promoting Cancer Progression.

Peter Vaupel1, Gabriele Multhoff2.   

Abstract

Inhospitable conditions within the tumor microenvironment (TME) are a characteristic feature ('hallmark') of most solid malignancies. Regional tumor hypoxia is a primary deficiency since it plays a key role in malignant progression. Severe hypoxia is often associated with other detrimental conditions in the TME as a consequence of hypoxia-/HIF-1α-induced (with/without oncogene-direction and/or reciprocal interaction of cancer cells with TME cells) metabolic re-programming, exorbitant extracellular adenosine (ADO) generation and VEGF overexpression/VEGF-R activation. Re-programming of the tumor metabolism inter alia includes a 'selfish' upregulation of aerobic glycolysis/glycolytic flux ('Warburg effect'), a strongly enhanced glutaminolysis in tumor cells, ketogenesis in cancer-associated fibroblasts, and an acceleration of the tryptophan uptake/intensified catabolism yielding kynurenine, which can support the malignant phenotype. Aerobic glycolysis and glutaminolysis result in lactate accumulation (up to 40 mM), and together with the enhanced ketogenesis and CO2/carbonic acid production lead to extracellular acidosis (pHe < 6.8). These traits of the TME individually or collectively operate towards cancer progression via e.g. promotion of genetic instability and mutation, resistance to apoptosis, clonal selection, limitless cell survival and sustained proliferation, continuous angiogenesis and tumor growth, local invasion and distant metastasis, anti-tumor immunosuppression and resistance to therapy.

Entities:  

Keywords:  Adenosine; Aerobic glycolysis; Glutaminolysis; HIF-1α; Lactate; Metabolic re-programming; Tumor acidosis; Tumor hypoxia; Tumor progression; VEGF; Warburg effect

Mesh:

Substances:

Year:  2020        PMID: 31893407     DOI: 10.1007/978-3-030-34461-0_21

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

Review 1.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

2.  Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.

Authors:  Mingjiu Chen; Zhenkun Xia; Jie Deng
Journal:  Cell Biol Toxicol       Date:  2022-10-12       Impact factor: 6.819

Review 3.  Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.

Authors:  Shun Li; David Mark Pritchard; Lu-Gang Yu
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

4.  CREB1 Suppresses Transcription of microRNA-186 to Promote Growth, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells Through the KRT8/HIF-1α Axis.

Authors:  Xue Huang; Fujian Liu; Zhiyong Jiang; Hang Guan; Qiuhong Jia
Journal:  Cancer Manag Res       Date:  2020-09-25       Impact factor: 3.989

Review 5.  The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.

Authors:  Giovanni Barillari
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

6.  Heparanase from triple‑negative breast cancer and platelets acts as an enhancer of metastasis.

Authors:  Wen-Jing Yang; Gan-Lin Zhang; Ke-Xin Cao; Xiao-Ni Liu; Xiao-Min Wang; Ming-Wei Yu; Jin-Ping Li; Guo-Wang Yang
Journal:  Int J Oncol       Date:  2020-08-27       Impact factor: 5.650

7.  Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.

Authors:  Michael R Horsman; Thomas R Wittenborn; Patricia S Nielsen; Pernille B Elming
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

Review 8.  Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics.

Authors:  Alia Ghoneum; Ammar Yasser Abdulfattah; Bailey Olivia Warren; Junjun Shu; Neveen Said
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 9.  Different polymorphisms in HIF-1α may exhibit different effects on cancer risk in Asians: evidence from nearly forty thousand participants.

Authors:  Yichen Liu; Xiaoqi Zhu; Xiaoyi Zhou; Jingwen Cheng; Xiaoyu Fu; Jingsheng Xu; Yuya Wang; Yueping Zhong; Minjie Chu
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

10.  Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells.

Authors:  Yajie Wang; Zhijia Li; Muzhou Teng; Junlin Liu
Journal:  Int J Med Sci       Date:  2021-05-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.